AHL Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $2.11M | Sell |
36,246
-72,730
| -67% | -$4.22M | 0.03% | 708 |
|
|
2017
Q3 | $4.89M | Sell |
108,976
-67,743
| -38% | -$3.04M | 0.09% | 411 |
|
|
2017
Q2 | $6.98M | Buy |
176,719
+31,401
| +22% | +$1.24M | 0.15% | 231 |
|
|
2017
Q1 | $5.9M | Buy |
145,318
+131,918
| +984% | +$5.35M | 0.13% | 282 |
|
|
2016
Q4 | $538K | Sell |
13,400
-2,019
| -13% | -$81.1K | 0.02% | 809 |
|
|
2016
Q3 | $558K | Sell |
15,419
-36,434
| -70% | -$1.32M | 0.02% | 800 |
|
|
2016
Q2 | $1.5M | Buy |
51,853
+44,597
| +615% | +$1.29M | 0.08% | 314 |
|
|
2016
Q1 | $254K | Sell |
7,256
-23,604
| -76% | -$826K | 0.02% | 697 |
|
|
2015
Q4 | $995K | Buy |
30,860
+18,113
| +142% | +$584K | 0.08% | 364 |
|
|
2015
Q3 | $412K | Buy |
12,747
+3,371
| +36% | +$109K | 0.07% | 446 |
|
|
2015
Q2 | $388K | Buy |
9,376
+3,049
| +48% | +$126K | 0.02% | 737 |
|
|
2015
Q1 | $284K | Buy |
6,327
+731
| +13% | +$32.8K | 0.01% | 721 |
|
|
2014
Q4 | $209K | Sell |
5,596
-1,592
| -22% | -$59.5K | 0.01% | 722 |
|
|
2014
Q3 | $251K | Buy |
+7,188
| New | +$251K | 0.02% | 640 |
|